Log In
BCIQ
Print this Print this
 

BNZ-2

  Manage Alerts
Collapse Summary General Information
Company Bioniz Therapeutics Inc.
DescriptionInterleukin-15 (IL-15) and IL-21 inhibitor
Molecular Target Interleukin-15 (IL-15) ; Interleukin-21 (IL-21)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationCeliac disease
Indication DetailsTreat celiac disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today